Delhi yet to receive more Covid-19 vaccines for 18-44 group, says Atishi

Delhi is yet to receive more vaccines for the 18-44 age group and only private hospitals are giving jabs to beneficiaries in this category for now, Aam Aadmi Party MLA Atishi said on Tuesday

Coronavirus, covid-19, vaccination, vaccine
Press Trust of India New Delhi
1 min read Last Updated : May 25 2021 | 7:41 PM IST

Delhi is yet to receive more vaccines for the 18-44 age group and only private hospitals are giving jabs to beneficiaries in this category for now, Aam Aadmi Party MLA Atishi said on Tuesday.

Delhi vaccinated 54,364 people on May 24.

This is the second day that there were no vaccines for the 18-44 age group, she said.

"Only private hospitals have been vaccinating beneficiaries in this category, that too in smaller numbers," Atishi said.

"Covaxin doses for those aged above 45 have also been exhausted. Around 3.25 lakh Covishield doses are remaining for this category and these can last up to 13 days," she said.

The AAP MLA said that the central government should grant approval for vaccines by foreign firms such as Moderna and Pfizer and ramp up production in India.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Aam Aadmi PartyAtishi MarlenaCoronavirus VaccineVaccinationVaccineBharat BiotechSerum Institute of IndiaAstraZeneca

First Published: May 25 2021 | 7:36 PM IST

Next Story